Weiqi Pan

Sar, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Redirecting NEU (neuraminidase) antigen to autophagosomes confers enhanced cross-reactive T-cell immunity against heterosubtypic influenza virus infection.

Redirecting NEU (neuraminidase) antigen to autophagosomes confers enhanced cross-reactive T-cell immunity against heterosubtypic influenza virus infection.

Journal: Autophagy

Published: February 08, 2026

Dynamic monitoring of a core pro-inflammatory cytokine panel improves mortality prediction in severe influenza.

Dynamic monitoring of a core pro-inflammatory cytokine panel improves mortality prediction in severe influenza.

Journal: Frontiers in immunology

Published: February 06, 2026

Integrated Simulation for Identifying the Key Driver of Strain-Specific Airborne Infectivity of Influenza Viruses.

Integrated Simulation for Identifying the Key Driver of Strain-Specific Airborne Infectivity of Influenza Viruses.

Journal: Environmental science & technology

Published: January 29, 2026

Molecular and antigenic characteristics of the influenza B virus in Guangzhou, 2022-2023.

Molecular and antigenic characteristics of the influenza B virus in Guangzhou, 2022-2023.

Journal: Virology journal

Published: November 28, 2025

Cathepsin S contributes to influenza-induced lung injury by driving inflammation, promoting apoptosis, and disrupting epithelial barrier integrity.

Cathepsin S contributes to influenza-induced lung injury by driving inflammation, promoting apoptosis, and disrupting epithelial barrier integrity.

Journal: Microbiology spectrum

Published: November 19, 2025

A semi-replicating VSV (srVSV)-based platform for developing broad-spectrum mucosal vaccines against influenza A viruses.

A semi-replicating VSV (srVSV)-based platform for developing broad-spectrum mucosal vaccines against influenza A viruses.

Journal: Virologica Sinica

Published: November 10, 2025

Erucic acid attenuates post-influenza secondary Staphylococcus aureus infection by modulating VCAM-1 and CEACAM-1 expression and gut dysbiosis.

Erucic acid attenuates post-influenza secondary Staphylococcus aureus infection by modulating VCAM-1 and CEACAM-1 expression and gut dysbiosis.

Journal: International immunopharmacology

Published: September 24, 2025

Genome-Wide Codon Reprogramming Enables a Multifactorially Attenuated Influenza Vaccine with Broad Cross-Protection.

Genome-Wide Codon Reprogramming Enables a Multifactorially Attenuated Influenza Vaccine with Broad Cross-Protection.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 25, 2025

Activity and mechanism of naringin in the treatment of post-infectious cough.

Activity and mechanism of naringin in the treatment of post-infectious cough.

Journal: BMC pulmonary medicine

Published: March 16, 2025

N460S in PB2 and I163T in nucleoprotein synergistically enhance the viral replication and pathogenicity of influenza B virus.

N460S in PB2 and I163T in nucleoprotein synergistically enhance the viral replication and pathogenicity of influenza B virus.

Journal: PLoS pathogens

Published: February 18, 2025

A Novel Matching Pursuit Modeling Strategy Based on Adaptive Fourier Decomposition Theory for Predicting Antigenic Variation of Influenza A (H1N1).

A Novel Matching Pursuit Modeling Strategy Based on Adaptive Fourier Decomposition Theory for Predicting Antigenic Variation of Influenza A (H1N1).

Journal: China CDC weekly

Published: December 12, 2024

A decavalent composite mRNA vaccine against both influenza and COVID-19.

A decavalent composite mRNA vaccine against both influenza and COVID-19.

Journal: mBio

Published: August 06, 2024

Showing 1-12 of 41

Last Updated: 09/26/2026